Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

10 May 2016 - 16 May 2016
11 May 2016 - 13 May 2016

Fructose Effects on Brain Influence Overeating

By BiotechDaily International staff writers
Posted on 14 Jan 2013
Print article
A new study suggests that consuming fructose appears to cause changes in regional cerebral blood flow (CBF) that can lead to overeating.

Researchers at Yale University (New Haven, CT, USA) used arterial spin labeling magnetic resonance imaging (MRI) to quantify regional CBF in 20 healthy normal-weight adult volunteers, both before and after drinking a 75-gram beverage of pure glucose or fructose. The main outcome measures were relative changes in hypothalamic regional CBF after ingestion. Secondary outcomes included whole-brain analyses to explore regional CBF changes, functional connectivity analysis to investigate correlations between the hypothalamus and other brain region responses, and hormone responses to fructose and glucose ingestion.

The results showed that glucose ingestion increased functional connectivity between the hypothalamus and the thalamus and striatum, while fructose increased connectivity between the hypothalamus and thalamus, but not the striatum. Regional CBF within the hypothalamus, thalamus, insula, anterior cingulate, and striatum--the appetite and reward regions-- was reduced after glucose ingestion; in contrast, fructose reduced regional CBF in the thalamus, hippocampus, posterior cingulate cortex, fusiform, and visual cortex. Fructose ingestion was also associated with reduced systemic levels of the satiety-signaling hormone insulin. The study was published in the January 2, 2012, issue of the Journal of the American Medical Association (JAMA).

“Fructose ingestion produces smaller increases in circulating satiety hormones compared with glucose ingestion, and central administration of fructose provokes feeding in rodents, whereas centrally administered glucose promotes satiety,” concluded lead author Kathleen Page, MD, and colleagues. “Thus, fructose possibly increases food-seeking behavior and increases food intake.”

Fructose (fruit sugar) is a simple monosaccharide found in many plants and together with glucose forms sucrose, the sugar we eat. It is one of the three dietary monosaccharides, along with glucose and galactose, which are absorbed directly into the bloodstream during digestion. Because fructose is metabolized in the liver to glucose, it has the lowest glycemic index (19) of all the natural sugars. Excess fructose consumption has been hypothesized to be a cause of insulin resistance, obesity, elevated LDL cholesterol, and triglycerides, leading to metabolic syndrome.

Related Links:
Yale University



Print article

Channels

Genomics/Proteomics

view channel
Image: An artistic rendering of the Zika virus structure (Photo courtesy of Dr. Guntur Fibriansah, Duke-NUS Medical School).

High Resolution Structure of Zika virus Expected to Aid Vaccine Development

A team of molecular virologists used advanced cryo-electron microscopy techniques to establish a high-resolution structure for the Zika virus, a formerly neglected pathogen that has recently been associated... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.